HK1254514A1 - 用於增强疫苗接種免疫反應的方法及組合物 - Google Patents
用於增强疫苗接種免疫反應的方法及組合物Info
- Publication number
- HK1254514A1 HK1254514A1 HK18113764.7A HK18113764A HK1254514A1 HK 1254514 A1 HK1254514 A1 HK 1254514A1 HK 18113764 A HK18113764 A HK 18113764A HK 1254514 A1 HK1254514 A1 HK 1254514A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- vaccination
- compositions
- methods
- immune response
- enhancing immune
- Prior art date
Links
- 230000002708 enhancing effect Effects 0.000 title 1
- 230000028993 immune response Effects 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 238000002255 vaccination Methods 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/145—Orthomyxoviridae, e.g. influenza virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
- C07K16/1018—Orthomyxoviridae, e.g. influenza virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
- A61K2039/575—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 humoral response
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16211—Influenzavirus B, i.e. influenza B virus
- C12N2760/16234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201562194136P | 2015-07-17 | 2015-07-17 | |
PCT/US2016/042561 WO2017015136A1 (en) | 2015-07-17 | 2016-07-15 | Methods and compositions for enhancing immune response to vaccination |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1254514A1 true HK1254514A1 (zh) | 2019-07-19 |
Family
ID=57834522
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK18113764.7A HK1254514A1 (zh) | 2015-07-17 | 2018-10-29 | 用於增强疫苗接種免疫反應的方法及組合物 |
Country Status (6)
Country | Link |
---|---|
US (2) | US10588903B2 (zh) |
EP (1) | EP3324963A4 (zh) |
CN (1) | CN108697692A (zh) |
HK (1) | HK1254514A1 (zh) |
TW (1) | TWI801328B (zh) |
WO (1) | WO2017015136A1 (zh) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3895731A1 (en) * | 2020-04-19 | 2021-10-20 | Englmeier, Ludwig | Method for emergency immunization of selected parts of a population |
WO2021213946A1 (en) * | 2020-04-19 | 2021-10-28 | Englmeier Ludwig | Prophylaxis and treatment of coronavirus infection |
WO2021217109A1 (en) * | 2020-04-25 | 2021-10-28 | Kang Zhang | Methods and compositions for enhancing immunogenicity of vaccine |
WO2022006565A1 (en) * | 2020-07-03 | 2022-01-06 | Kang Zhang | Polypeptides, vaccine compositions, and use thereof for inducing immune response to sars-cov-2 in primates |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060002949A1 (en) * | 1996-11-14 | 2006-01-05 | Army Govt. Of The Usa, As Rep. By Secretary Of The Office Of The Command Judge Advocate, Hq Usamrmc. | Transcutaneous immunization without heterologous adjuvant |
AU2004266162A1 (en) * | 2003-08-25 | 2005-03-03 | 3M Innovative Properties Company | Immunostimulatory combinations and treatments |
US20090060928A1 (en) * | 2006-05-26 | 2009-03-05 | Jean-Claude Bystryn | Topical Toll Like Receptor Ligands as Vaccine Adjuvants |
WO2008147489A1 (en) * | 2007-05-25 | 2008-12-04 | Jean-Claude Bystryn | Topical toll-like receptor ligands as vaccine adjuvants |
WO2014145290A1 (en) * | 2013-03-15 | 2014-09-18 | The Research Foundation For The State University Of New York | Attenuated influenza viruses and vaccines |
US10420836B2 (en) * | 2015-10-08 | 2019-09-24 | Emory University | Methods of immunizing a subject and compositions related thereto |
-
2016
- 2016-07-13 TW TW105122118A patent/TWI801328B/zh active
- 2016-07-15 US US15/745,411 patent/US10588903B2/en active Active
- 2016-07-15 EP EP16828317.4A patent/EP3324963A4/en active Pending
- 2016-07-15 WO PCT/US2016/042561 patent/WO2017015136A1/en active Application Filing
- 2016-07-15 CN CN201680053236.9A patent/CN108697692A/zh active Pending
-
2018
- 2018-10-29 HK HK18113764.7A patent/HK1254514A1/zh unknown
-
2020
- 2020-01-29 US US16/776,403 patent/US11357773B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
CN108697692A (zh) | 2018-10-23 |
TWI801328B (zh) | 2023-05-11 |
US11357773B2 (en) | 2022-06-14 |
WO2017015136A1 (en) | 2017-01-26 |
TW201718009A (zh) | 2017-06-01 |
US20200163957A1 (en) | 2020-05-28 |
EP3324963A1 (en) | 2018-05-30 |
US10588903B2 (en) | 2020-03-17 |
EP3324963A4 (en) | 2019-03-20 |
US20180207149A1 (en) | 2018-07-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1258041A1 (zh) | 免疫細胞組合物和使用方法 | |
ZA201801035B (en) | Vaccine compositions | |
HK1259190A1 (zh) | 嵌合抗原受體相關的方法和組合物 | |
IL249011B (en) | Methods and preparations related to exosomes | |
GB2535253B (en) | Compositions and methods | |
IL250818A0 (en) | Methods and preparations for increasing immune responses | |
HK1252695A1 (zh) | 用於消除對治療劑的免疫應答的改進方法和化合物 | |
IL250902A0 (en) | Anti-met antibodies and preparations | |
IL247614B (en) | Methods and preparations for changing the immune response | |
IL248223A0 (en) | Compositions of vaccine | |
HK1250637A1 (zh) | 用於引發免疫應答的劑和組合物 | |
HK1254514A1 (zh) | 用於增强疫苗接種免疫反應的方法及組合物 | |
GB2556002B (en) | Methods and compositions for nanoemulsion vaccine formulations | |
HK1259146A1 (zh) | 用於流感疫苗接種的方法和組合物 | |
DK3380120T3 (da) | Immunstimulerende sammensætninger | |
IL245509B (en) | Compositions and methods for inducing an enhanced immune response using pox virus vectors | |
HK1248253A1 (zh) | 對修飾的自體表位的抗腫瘤免疫應答 | |
SG11201701402QA (en) | Anti-tumor compositions and methods | |
EP3097420A4 (en) | Methods and compositions for immune dis-inhibition | |
IL248877B (en) | Preparations and methods for improving immunity | |
PL3223846T3 (pl) | Kompozycje adiuwantowe i powiązane sposoby | |
ZA201703123B (en) | Combination long acting compositions and methods for hepatitis c | |
IL252600A0 (en) | Preparations for the treatment of hyperproliferation | |
GB201402915D0 (en) | Compositions and methods | |
GB201521608D0 (en) | Vaccine composition |